Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Adynxx Inc

ADYX
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US00784D1037
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 87 118 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
ADYX
21.11.2021 - 28.11.2021

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California. Address: 100 Pine Street, San Francisco, CA, United States, 94111

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.8 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ADYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 869 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -192.35 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 2.8 USD
Revenue TTM
Book Value -1.91 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.03 USD
Diluted Eps TTM -0.03 USD
Most Recent Quarter III 2019
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADYX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

-10 %

Dividend History ADYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 06.05.2019
Forward Annual Dividend Yield
Last Split Factor 1:6
Payout Ratio
Last Split Date 06.05.2019
Dividend Date 29.05.2019

Stock Valuation ADYX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 20.0872
Price Sales TTM 0.0926
Enterprise Value EBITDA -1.3057
Price Book MRQ

Financials ADYX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADYX

For 52 weeks

0.0001 USD 0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 18 067
200 Day MA 0.0001 USD
Short Ratio 2.86
Shares Short 25 825
Short Percent 0.46 %